Program Summary: Digital health and technology use has changed drastically since the 2020 pandemic. It is important for Allergists to understand how digital health can be utilized in their practices and how it is being utilized in direct-to-consumer business mod...

Program Summary: Epinephrine is the first line therapy to treat anaphylaxis yet remains underused for a variety of reasons, including fear of needle injection or concern for adverse effects. New delivery devices, including sublingual and intranasal epinephrine, may ...

Program Summary: The etiology and management of chronic cough is challenging for both patient and provider due to the wide differential and/or multifactorial nature. Understanding the mechanisms that lead to cough is paramount.

Program Summary: Join Dr. James Tracy to learn all about the basics of biologics and how you can incorporate them into your work.

Program Summary: Chronic obstructive pulmonary disease (COPD) therapies have been fairly limited for several decades, however, this may be due to approaching the heterogeneous disease of COPD as a single homogenous disease. A better understanding of phenotypes may al...

Program Summary: Despite much innovation in the diagnosis and treatment of asthma, significant disparities in asthma prevalence and outcomes exist across racial and ethnic groups in the United States

Program Summary: Many new treatments for AD have been approved since Dec 2021, and now more than ever allergists need to familiarize themselves with the many new options for treating this common and potentially debilitating disease in a constantly evolving field.

Program Summary: Join Dr. Moisés Calderón to discuss the advantages and limitations of Single vs. Multiple Allergens Approaches to SLIT